0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 31, 2022Exploring the effects of a brief online self-implemented mindfulness-based task: A pilot study READ MORE
0 By Tennille Luker In NSW, QLD, TAS, VIC, WAPosted August 30, 2022A study to investigate the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in participants with multiple sclerosis READ MORE
0 By Tennille Luker In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WAPosted August 9, 2022Recommendations for a core outcome set for evaluating falls prevention interventions among adults with Multiple Sclerosis, Parkinson’s Disease and stroke: A Consensus-Based Approach READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 3, 2022Investigating social cognitive factors associated with chronic non-cancer pain and pain management READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted June 23, 2022Crisis Resilience in MS; considering experience of persons with MS to improve crisis and disaster management READ MORE
0 By Tennille Luker In QLD, VICPosted June 21, 2022An early feasibility study of the safety of an endovascular Motor Neuroprosthesis (MNP) in participants with severe upper limb dysfunction READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted June 16, 2022The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis READ MORE
0 By Tennille Luker In QLDPosted June 1, 2022Reducing the frequency of Autoimmune adverse events in the treatment of Multiple sclerosis with alemtuzumab using B-celL dEpletion (RAMBLE): a phase II, randomised, placebo-controlled clinical trial READ MORE
0 By Tennille Luker In NSW, QLD, VIC, WAPosted May 31, 2022An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS) READ MORE
0 By Tennille Luker In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WAPosted May 30, 2022Cellular Horizons: Improving decisions about access to stem cell interventions READ MORE
